Nautilus Biotechnology, Inc.
NAUT
$0.6884
-$0.0246-3.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.16% | -16.90% | -19.57% | -18.05% | -9.93% |
| Total Depreciation and Amortization | 11.36% | 26.89% | 41.88% | 61.99% | 67.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.33% | 5.89% | 3.85% | 1.10% | -0.13% |
| Change in Net Operating Assets | -69.59% | -93.08% | -128.06% | -72.57% | -308.50% |
| Cash from Operations | -14.38% | -21.89% | -24.66% | -20.56% | -12.89% |
| Capital Expenditure | -18.02% | -1.02% | -4.22% | 5.44% | -5.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 267.42% | 85.06% | 112.42% | 89.42% | -76.35% |
| Cash from Investing | 251.48% | 82.14% | 109.44% | 85.51% | -69.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 210.87% | 282.80% | 160.31% | 50.37% | -34.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 210.87% | 282.80% | 160.31% | 50.37% | -34.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.68% | 39.22% | 65.17% | 37.28% | -33.94% |